CLINICAL TRIALS, STUDIES, REGISTRIES, DATA

Editas Medicine Reports New Safety and Efficacy Data from the RUBY Trial of Reni-cel in 18 Patients with Sickle Cell Disease | Presented at the European Hematology Association (EHA) Annual Congress

“These data confirm the observations from our prior clinical readouts [...]

By |2024-06-14T09:10:47+00:00June 14, 2024|3rd Party Medical Device Industry News|Comments Off on Editas Medicine Reports New Safety and Efficacy Data from the RUBY Trial of Reni-cel in 18 Patients with Sickle Cell Disease | Presented at the European Hematology Association (EHA) Annual Congress

Innovent Biologics Delivers Oral Presentation on Clinical Data of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Advanced Non-small Cell Lung Cancer and Other Solid Tumors at the 2024 ESMO Virtual Plenary

Dr. Hui Zhou, Senior Vice President of Innovent, stated: “IBI363, [...]

By |2024-06-14T09:03:24+00:00June 14, 2024|3rd Party Medical Device Industry News|Comments Off on Innovent Biologics Delivers Oral Presentation on Clinical Data of IBI363 (First-in-class PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Advanced Non-small Cell Lung Cancer and Other Solid Tumors at the 2024 ESMO Virtual Plenary

Deciphera Pharmaceuticals Announces Oral Presentation of Results from MOTION Pivotal Phase 3 Study of Vimseltinib in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the 2024 ASCO Annual Meeting and Online Publication in The Lancet

Deciphera Pharmaceuticals notes the article titled “Vimseltinib versus placebo for [...]

By |2024-06-03T11:43:56+00:00June 3, 2024|3rd Party Medical Device Industry News|Comments Off on Deciphera Pharmaceuticals Announces Oral Presentation of Results from MOTION Pivotal Phase 3 Study of Vimseltinib in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the 2024 ASCO Annual Meeting and Online Publication in The Lancet

In a Usability Analysis of the ArthroFree Wireless Surgical Camera by Lazurite®, More than 90% of Respondents Agree the Absence of Cables Will Have a Positive Impact on Efficiency and Patient Safety

Medical device and technology company Lazurite® announced that a new [...]

By |2024-01-26T16:42:33+00:00January 26, 2024|3rd Party Medical Device Industry News|Comments Off on In a Usability Analysis of the ArthroFree Wireless Surgical Camera by Lazurite®, More than 90% of Respondents Agree the Absence of Cables Will Have a Positive Impact on Efficiency and Patient Safety
Go to Top